Expression of the monocyte chemotactic protein-1-induced protein 1 decreases human neuroblastoma cell survival

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2385-2392

  Skalniak, Anna ^a,c   Boratyn, Elzbieta ^a   Tyrkalska, Sylwia D ^a,d   Horwacik, Irena ^a   Durbas, Małgorzata ^a   Lastowska, Maria ^b   Jura, Jolanta ^a   Rokita, Hanna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Monocyte chemotactic protein 1 induced protein 1; Neuroblastoma; PIN domain; Tumor growth; ZC3H12A

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1 INDUCED PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; RIBONUCLEASE; ZC3H12A PROTEIN, HUMAN;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MCPIP1 GENE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT; BIOSYNTHESIS; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENDORIBONUCLEASES; GENE EXPRESSION; HUMANS; NEUROBLASTOMA; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84898618997     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3076     Document Type: Article

References (33)

1. Zhou L, Azfer A, Niu J, Graham S, Choudhury M, Adamski FM, Younce C, Binkley PF and Kolattukudy PE: Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 98: 1177-1185, 2006
2. Vrotsos EG, Kalattukudy PE and Sugaya K: MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling. Brain Res Bull 79: 97-103, 2009
3. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, Miyake T, Satoh T, Kato H, Tsujimura T, Nakamura H and Akira S: Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458: 1185-1190, 2009
4. Mizgalska D, Wegrzyn P, Murzyn K, Kasza A, Koj A, Jura J, Jarz?b B and Jura J: Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase participating in degradation of IL-1? mRNA. FEBS J 276: 7386-7399, 2009
5. Liang J, Saad Y, Lei T, Wang J, Qi D, Yang Q, Kolattukudy PE and Fu M: MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-?B signaling. J Exp Med 207: 2959-2973, 2010
6. Jura J, W?grzyn P, Korosty?ski M, Guzik K, Oczko-Wojciechowska M, Jarz?b M, Kowalska M, Piechota M, Przew?ocki R and Koj A: Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochim Biophys Acta 1799: 383-389, 2008
7. Liang J, Wang J, Azfer A, Song W, Tromp G, Kolattukudy PE and Fu M: A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 283: 6337-6346, 2008
8. Jura J, Skalniak ? and Koj A: Monocyte-chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. Biochim Biophys Acta 1823: 1905-1913, 2012
9. Lin RJ, Chien HL, Lin SY, Chang BL, Yu HP, Tang WC and Lin YL: MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res 41: 3314-3326, 2013
10. Skalniak L, Koj A and Jura J: Proteasome inhibitor MG-132 induces MCPIP1 expression. FEBS J 280: 2665-2674, 2013
11. Suzuki HI, Arase M, Matsuyama H, Choi YL, Ueno T, Mano H, Sugimoto K and Miyazono K: MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol Cell 44: 424-436, 2011
12. Garzon R, Calin GA and Croce CM: MicroRNAs in cancer. Annu Rev Med 60: 167-170, 2009
13. Deshmane SL, Kremlev S, Amini S and Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 29: 313-326, 2009
14. Muramatsu T and Muramatsu H: Glycosaminoglycan-binding cytokines as tumor markers. Proteomics 8: 3350-3359, 2008
15. ?astowska M, Viprey V, Santibanez-Koref M, Wappler I, Peters H, Cullinane C, Roberts P, Hall AG, Tweddle DA, Pearson ADJ, Lewis I, Burchill SA and Jackson MS: Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene 26: 7432-7444, 2007
16. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsi? A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC and Versteeg R: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3: E3088, 2008
17. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG and Baker SJ: Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28: 3061-3068, 2010
18. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG and Gilbertson RJ: Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466: 632-636, 2010
19. Bogenmann E: A metastatic neuroblastoma model in SCID mice. Int J Cancer 67: 379-385, 1996
20. Gauthier ER, Madison SD and Michel RN: Rapid RNA isolation without the use of commercial kits: Application to small tissue samples. Eur J Physiol 433: 664-668, 1997
21. Smith PK: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985
22. Pomerantz JL and Baltimore D: Two pathways to NF-?B. Mol Cell 10: 693-695, 2002
23. Ueda A, Ishigatsubo Y, Okubo T and Yoshimura T: Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-?B sites and NF-?B/Rel subunit specificity. J Biol Chem 272: 31092-31099, 1997
24. Skalniak L, Mizgalska D, Zarebski A, Wyrzykowska P, Koj A and Jura J: Regulatory feedback loop between NF-?B and MCP-1-induced protein 1 RNase. FEBS J 276: 5892-5905, 2009
25. Brodeur GM: Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216, 2003
26. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007
27. Ora I and Eggert A: Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research. Semin Cancer Biol 21: 217-228, 2011
28. Metelitsa LS, Wu HW, Wang, H, Yang Y, Warsi Z, Asgharzadeh S, Groshen S, Wilson SB and Seeger RC: Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med 199: 1213-1221, 2004
29. Song L, Ara T, Wu HW, Woo CW, Reynolds CP, Seeger RC, DeClerck YA, Thiele CJ, Sposto R and Metelitsa LS: Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. J Clin Invest 117: 2702-2712, 2007
30. Iwasaki H, Takeuchi O, Teraguchi S, Matsushita K, Uehata T, Kuniyoshi K, Satoh T, Saitoh T, Matsuhita M, Standley DM and Akira S: The I?B kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat Immunol 12: 1167-1175, 2011
31. Chen Y and Stallings RL: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation and apoptosis. Cancer Res 67: 976-983, 2007
32. Xu J, Fu S, Peng W and Rao Z: MCP-1-induced protein-1, an immune regulator. Protein Cell 3: 903-910, 2012
33. Clissold PM and Ponting CP: PIN domain in nonsense-mediated mRNA decay and RNAi. Curr Biol 10: R888-R890, 2000